Use of the 21-gene Oncotype DX® Breast Recurrence Score™ (RS) assay in the neoadjuvant treatment setting

被引：2
|
作者：
Robidoux, A. [1 ]
McCullough, D. [2 ]
Lau, A. [2 ]
Stoppler, M. [2 ]
Chao, C. [2 ]
机构：
[1] Ctr Hosp Univ Montreal, Montreal, PQ, Canada
[2] Genom Hlth Inc, Redwood City, CA USA
来源：
BREAST | 2017年 / 32卷
关键词：
D O I：
10.1016/S0960-9776(17)30262-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P171
引用
收藏
页码：S80 / S80
页数：1
相关论文
共 50 条
  • [1] Change in 21-gene recurrence score (RS) (Oncotype DX) after exposure to neoadjuvant endocrine therapy.
    Hilal, Talal
    Mi, Lanyu
    Anderson, Karen S.
    Pockaj, Barbara A.
    Gray, Richard J.
    Dixon, Leslie E.
    Martinez, Erika D.
    Singh, Charanjit
    Northfelt, Donald W.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [2] Distribution of the 21-gene recurrence score (RS) assay (Oncotype DX) in carriers of germline mutations associated with breast cancer predisposition syndromes
    Giridhar, Karthik V.
    Choong, Grace M.
    Yadav, Siddartha
    Polley, Eric C.
    Leon-Ferre, Roberto A.
    Liu, Minetta C.
    Goetz, Matthew P.
    Couch, Fergus J.
    CANCER RESEARCH, 2020, 80 (04)
  • [3] 21-Gene Oncotype DX® Recurrence-Score benefits and application in elderly breast cancer patients
    Chiru, E. D.
    Kuhar, C. Grasic
    Oseledchyk, A.
    Kurzeder, C.
    Vetter, M.
    SWISS MEDICAL WEEKLY, 2022, 152 : 43S - 43S
  • [4] Evaluation Oncotype DX® 21-Gene Recurrence Score and clinicopathological parameters in early stage breast cancer
    Lashen, A. L.
    Toss, M. T.
    Fadhil, W. F.
    Oni, G. O.
    Madhusudan, S. M.
    Rakha, E. R.
    JOURNAL OF PATHOLOGY, 2023, 261 : S10 - S10
  • [5] Appropriate use of the 21-gene recurrence score (RS) assay across Michigan
    Ali, H. Y.
    Munir, K.
    Braun, T.
    Griggs, J. J.
    Silver, S. M.
    Gorski, D. H.
    Breslin, T. M.
    Henry, N. L.
    CANCER RESEARCH, 2016, 76
  • [6] The Evolving Role of the 21-gene Recurrence Score in the Neoadjuvant Setting
    Albaneze, Philip
    Aggon, Allison
    Bleicher, Richard
    Chang, Cecilia
    Daly, John
    Sharp, Nicole
    Sigurdson, Elin
    Wang, Edward
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 2) : S420 - S421
  • [7] Genetic Ancestry and 21-Gene Oncotype DX Breast Cancer Recurrence Scores
    Borowsky, Peter A.
    Hernandez, Alexandra E.
    Kesmodel, Susan B.
    Goel, Neha
    ANNALS OF SURGICAL ONCOLOGY, 2025,
  • [8] Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence between Breast Cancer Index (BCI) and 21-gene Oncotype DX Recurrence Score (RS)
    Patel, Rima
    Casasanta, Nicole
    Li, Zhiqiang
    Kier, Melanie
    Blanter, Julia
    Sohval, Sophie
    Hovstadius, Malin
    Wu, Catherine
    Fink, Marc
    Zhou, Xiang
    Zimmerman, Brittney
    Cascetta, Krystal
    Chen, Rong
    Oh, William
    Tiersten, Amy
    CANCER RESEARCH, 2023, 83 (05)
  • [9] Practice-changing use of 21-gene oncotype DX breast recurrence score assay in a public hospital in Brazil: Results of 155 cases.
    Mattar, Andre
    Fonseca, Guilherme Ribeiro
    Agudo Romao, Murilo Barato
    Shida, Jorge Yoshinori
    Agata Stiepcich, Monica Maria
    Jakubowski, Debbie M.
    Chao, Calvin Y.
    Oliveira, Sergio C.
    Gebrim, Luiz Henrique
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] Correlating Predicted Adjuvant Therapy Benefit and Risk of Recurrence Between Breast Cancer Index (BCI) and the 21-Gene Oncotype DX Recurrence Score (RS)
    Casasanta, Nicole
    Patel, Rima
    Raymond, Samantha
    Kier, Melanie W.
    Blanter, Julia
    Sohval, Sophie
    Hovstadius, Malin
    Wu, Catherine
    Zimmerman, Brittney
    Cascetta, Krystal
    Bagiella, Emilia
    Tiersten, Amy
    CLINICAL BREAST CANCER, 2024, 24 (07) : 585 - 596
12345